Reduction in Platelet Reactivity With Prasugrel 5 mg in Low-Body-Weight Patients Is Noninferior to Prasugrel 10 mg in Higher-Body-Weight Patients: Results From the FEATHER Trial - Erlinge, D; ten Berg, JM; Foley, D (J Am Coll Cardiol, 2012)
et al.